SimCorp A/S
Company Announcement no. 05/2021
On February 10, 2021 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR.
In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from February 10, 2021 to July 31, 2021.
The following transactions have been executed under the program:
| Date | Number of shares | Average purchase price (DKK per share) | Amount (DKK) |
| Accumulated under the program as of last announcement: | 22,900 | 807.39 | 18,489,165 |
| February 22, 2021 | 3,000 | 790.23 | 2,370,690 |
| February 23, 2021 | 4,500 | 758.12 | 3,411,540 |
| February 24, 2021 | 4,000 | 766.53 | 3,066,120 |
| February 25, 2021 | 3,500 | 756.82 | 2,648,870 |
| February 26, 2021 | 4,000 | 748.71 | 2,994,840 |
| Accumulated under the program following above purchases: | 41,900 | 787.14 | 32,981,225 |
Following above purchases, SimCorp holds 743.587 treasury shares corresponding to 1.8% of the share capital.
Purchases for an amount of EUR 15.6m (approx. DKK 115.8m) remain to be executed under the program.
Enquiries regarding this announcement should be addressed to:
Anders Hjort, Head of Investor Relations, SimCorp A/S (+45 3544 8822)
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd24.12.2025 14:36:11 CET | Press release
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
The Magnum Ice Cream Company N.V.24.12.2025 11:52:30 CET | Press release
Director/PDMR Shareholding
Afarak Group SE24.12.2025 10:00:00 CET | Press release
AFARAK GROUP SE: DISTRIBUTION OF ASSETS FROM THE RESERVE FOR INVESTED UNRESTRICTED EQUITY
Sanofi Winthrop Industrie24.12.2025 07:15:00 CET | Press release
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
FLSmidth A/S24.12.2025 07:00:00 CET | Press release
FLSmidth: Transactions under share buy-back programme
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
